Concepedia

Malte Ritter

MR

Statistics

Publications

6

Citations

175

H-Index

6

Active since

2019

Affiliations

University of Tübingen(Current)

University Children's Hospital Tübingen

Medizinische Hochschule Hannover

Max Planck Society

STZ eyetrial

Malte Ritter is an author at University of Tübingen specializing in hematopoietic differentiation, life sciences, and hematology.

ORCID

Publications per year

2019–2024

6

Publications

6

CRISPR/Cas9-mediated <i>ELANE</i> knockout enables neutrophilic maturation of primary hematopoietic stem and progenitor cells and induced pluripotent stem cells of severe congenital neutropenia patients

Masoud Nasri, Malte Ritter, Perihan Mir et al. · Haematologica · 2019 · 59 citations · Full text

, , +16

LMO2 activation by deacetylation is indispensable for hematopoiesis and T-ALL leukemogenesis

Tatsuya Morishima, Ann-Christin Krahl, Masoud Nasri et al. · Blood · 2019 · 43 citations · Full text

, , +12

iPSC modeling of stage-specific leukemogenesis reveals BAALC as a key oncogene in severe congenital neutropenia

Benjamin Dannenmann, Maksim Klimiankou, Benedikt Oswald et al. · Cell stem cell · 2021 · 28 citations · Full text

, , +14

CRISPR-Cas9n-mediated ELANE promoter editing for gene therapy of severe congenital neutropenia

Masoud Nasri, Malte Ritter, Perihan Mir et al. · Molecular Therapy · 2024 · 18 citations · Full text

, , +13

A topological refactoring design strategy yields highly stable granulopoietic proteins

Julia Skokowa, Birte Hernandez Alvarez, M.P. Coles et al. · Nature Communications · 2022 · 15 citations · Full text

, , +15

1–5 of 6